Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 15 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
AB0339 EFFICACY, PHARMACOKINETICS AND SAFETY BETWEEN CT-P13 AND CHINA-APPROVED INFLIXIMAB: 54 WEEK RESULT FROM A PHASE III RANDOMIZED CONTROLLED TRIAL IN CHINESE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
Jonathan Kay, Xiaoli Zeng, L. Chen,Kaijiang Tang,Guixiu Shi, L. Liu, Longfei Wu, Y. Liu, Junyi Hu, S. Liu, Z. Yi, S. H. Kim,Yun Ju Bae,Jee Hye Suh, S. Rhee, S. Lee, C.C. Hwang
Annals of the Rheumatic Diseasesno. Suppl 1 (2022): 1294.1-1294
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 15

#Citation: 270

H-Index: 8

G-Index: 10

Sociability: 5

Diversity: 3

Activity: 5

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn